ImageneBio, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from ImageneBio, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 2.9 times its market value (net cash). Higher than 97% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-21.2×Operating cash was negative last year, while some debt falls due within a year.
Lower than 55% of Healthcare companies in United States.
Cash Cushion Ratio
2.9× cashCash, after subtracting all debt, is 2.9 times its market value (net cash).
Higher than 97% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
ImageneBio, Inc. made a loss over the last year. ImageneBio, Inc. owes $0.07 for every $1 it owns. ImageneBio, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossImageneBio, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.32The share price is 0.32 times ImageneBio, Inc.'s book value per share, lower than 96% of Healthcare companies in United States.
Market cap
$46 MThe total market value of all of ImageneBio, Inc.'s shares at today's price (share price × number of shares), smaller than 75% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$142 MWhat ImageneBio, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$12.49Net worth divided by the number of shares. The share price of $4.05 is 0.3 times this, which is the P/B above.
Return on equity (ROE)
-82.7%ImageneBio, Inc. lost 82.7% of its shareholders' money over the last year, lower than 66% of Healthcare companies in United States.
Owes vs Owns
0.07×ImageneBio, Inc. owes $0.07 for every $1 it owns (low), lower than 93% of Healthcare companies in United States.
Dividend yield
NoneImageneBio, Inc. does not currently pay a dividend.
Revenue growth
-77%Revenue fell 77% in the year to Dec 2025.
Profit growth
LossImageneBio, Inc. made a loss in each of the last two years.
Profit margin
-5668.6%ImageneBio, Inc. lost $5669 for every $100 of revenue.
Cash vs debt
Net cashImageneBio, Inc. held $132 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For ImageneBio, Inc.: $46 M ÷ $142 M (30 Jun 2026) = 0.3.
What is ImageneBio, Inc.'s return on equity?
ImageneBio, Inc. lost 82.7% of its shareholders' money over the last year, lower than 66% of Healthcare companies in United States.
How much does ImageneBio, Inc. owe compared with what it owns?
ImageneBio, Inc. owes $0.07 for every $1 it owns (low), lower than 93% of Healthcare companies in United States.
Does ImageneBio, Inc. pay a dividend?
No. ImageneBio, Inc. does not currently pay a dividend.
Is ImageneBio, Inc.'s revenue growing?
Revenue fell 77% in the year to Dec 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.